|
Market Closed -
Nasdaq
00:00:00 07/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 1.220 USD | -3.17% |
|
-13.48% | -82.87% |
| 08-26 | Scinai Immunotherapeutics Ltd., H1 2026 Earnings Call, Aug 26, 2026 | |
| 08-24 | Scinai Immunotherapeutics Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
EPS & Dividend: Scinai Immunotherapeutics Ltd.
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2025 |
|---|---|---|---|---|---|
| Dividend per Share 2 | - | - | - | - | - |
| Rate of return | - | - | - | - | - |
| EPS 2 | -402 | -2,833 | -400 | -166.4 | -35.58 |
| Distribution rate | - | - | - | - | - |
| Reference price 2 | 2,810.000 | 2,350.000 | 296.000 | 59.540 | 7.121 |
| Nbr of stocks (in thousands) | 11.5 | 18.5 | 34.9 | 43.5 | 347 |
| Announcement Date | 13/05/21 | 28/03/22 | 17/04/23 | 15/05/24 | 01/04/26 |
1USD in Million2USD
Estimates
Past dividends: Scinai Immunotherapeutics Ltd.
| 21/08/2026 | Significant Split/Dividend | 08:00 |
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | ||
|---|---|---|---|---|---|---|
 | 1.37% | 1.5% | 21.73x | 5.12x | 7.72x | |
| 0.04% | 0.09% | 29.59x | 5.86x | 8.5x | |
| 0.97% | 1.11% | 33.52x | 4.5x | 6.02x | |
| -.--% | -.--% | -21.51x | 22.51x | 223.61x | |
| -.--% | -.--% | 34.27x | 6.37x | 3.31x | |
| -.--% | -.--% | 47.24x | 7.73x | 5.47x | |
| 0.41% | 0.43% | 27.63x | 2.23x | 7.93x | |
| -.--% | -.--% | 33.5x | 3.52x | 7.16x | |
| -.--% | -.--% | -15.28x | 1.25x | 5.82x | |
| Average | 0.31% | 0.35% | 21.19x | 6.57x | 30.62x | |
| Weighted average by Cap. | 0.42% | 0.47% | 22.51x | 6.94x | 31.17x |
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
